BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12908362)

  • 1. [Long-term prophylaxis after venous thromboembolism].
    Gøtze JP; Friis-Hansen LJ; Thorsen S; Rehfeld JF
    Ugeskr Laeger; 2003 Jul; 165(29):2896-7. PubMed ID: 12908362
    [No Abstract]   [Full Text] [Related]  

  • 2. [There is evidence for prolonged low-intensity warfarin therapy after venous thrombosis].
    Schulman S
    Lakartidningen; 2003 Jun; 100(24):2118-21. PubMed ID: 12841107
    [No Abstract]   [Full Text] [Related]  

  • 3. Initiating warfarin therapy: 5 mg versus 10 mg.
    Eckhoff CD; Didomenico RJ; Shapiro NL
    Ann Pharmacother; 2004 Dec; 38(12):2115-21. PubMed ID: 15522981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended anticoagulation for a first episode of idiopathic venous thromboembolism.
    Sparano N; English R
    J Fam Pract; 1999 Aug; 48(8):579-80. PubMed ID: 10496632
    [No Abstract]   [Full Text] [Related]  

  • 5. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Seneviratne C; Kupfer Y; Tessler S
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12879892
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery.
    Enyart JJ; Jones RJ
    Ann Pharmacother; 2005 Jun; 39(6):1002-7. PubMed ID: 15886295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Krishnan JA; Streiff MB
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12879888
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    van Dongen CJ; Prins MH; Büller HR
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12878749
    [No Abstract]   [Full Text] [Related]  

  • 9. Duration of anticoagulation after first episode of unprovoked venous thromboembolism.
    Abdel-Razeq HN; Radwi GR
    Saudi Med J; 2004 Nov; 25(11):1776; author reply 1776-7. PubMed ID: 15573235
    [No Abstract]   [Full Text] [Related]  

  • 10. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Aberegg SK
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12879891
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Cosmi B; Palareti G
    N Engl J Med; 2003 Jul; 349(4):398-400; author reply 398-400. PubMed ID: 12879889
    [No Abstract]   [Full Text] [Related]  

  • 12. Long term anticoagulation of idiopathic venous thromboembolism: do we have the answers?
    Goldhaber S
    Clin Adv Hematol Oncol; 2003 May; 1(5):276-7. PubMed ID: 16224420
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term anticoagulation prophylaxis following acute thromboembolism.
    Hyers TM
    Dis Mon; 2005; 51(2-3):158-65. PubMed ID: 15900268
    [No Abstract]   [Full Text] [Related]  

  • 14. Warfarin for venous thromboembolism - walking the dosing tightrope.
    Schafer AI
    N Engl J Med; 2003 Apr; 348(15):1478-80. PubMed ID: 12601074
    [No Abstract]   [Full Text] [Related]  

  • 15. Warfarin prophylaxis after total knee arthroplasty.
    Lieberman JR
    Am J Knee Surg; 1999; 12(1):49-53. PubMed ID: 10050694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term prophylaxis in venous thromboembolism: LMWH or oral anticoagulation?
    Schulman S
    Haemostasis; 1998; 28 Suppl 3():17-21. PubMed ID: 10069758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation period in idiopathic venous thromboembolism. How long is enough?
    Farraj RS
    Saudi Med J; 2004 Jul; 25(7):848-51. PubMed ID: 15235686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary prophylaxis with warfarin for venous thromboembolism.
    Büller HR; Prins MH
    N Engl J Med; 2003 Aug; 349(7):702-4. PubMed ID: 12917308
    [No Abstract]   [Full Text] [Related]  

  • 19. Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
    Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandala M; Papaldo P; Nistico C; Fabi A; Cuppone F; Gelibter A; Terzoli E; Cognetti F
    J Clin Oncol; 2005 Oct; 23(28):7248-50; author reply 7250. PubMed ID: 16192623
    [No Abstract]   [Full Text] [Related]  

  • 20. Secondary prophylaxis of venous thromboembolism: rational use of oral anticoagulants.
    Piovella F; Siragusa S; Barone M; Beltrametti C; Carbone S; Vicentini L; Ascari E
    Haematologica; 1995; 80(2 Suppl):87-91. PubMed ID: 7543072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.